期刊
BIOTECHNOLOGY JOURNAL
卷 13, 期 6, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/biot.201700628
关键词
antimicrobial peptides; fusion protein strategy; genetically modified barley; heterologous expression; LL-37
资金
- National Program of Sustainability I, Ministry of Education, Youth and Sports, Czech Republic [LO1204]
- Czech Science Foundation [17-07805S]
- biotech company Usovsko, a.s.
The peptide LL-37, a component of the human innate immune system, represents a promising drug candidate. In particular, the development of low-cost production platform technology is a critical bottleneck in its use in medicine. In the present study, a viable approach for the LL-37 production in transgenic barley is developed. First, comparative analyses of the effects of different fused peptide epitope tags applicable for accumulation and purification on LL-37 production yield are performed using transient expression in tobacco leaves. Following the selection of the most yielding fusion peptide strategies, eight different constructs for the expression of codon optimized chimeric LL-37 genes in transgenic barley plants are created. The expression of individual constructs is driven either by an endosperm-specific promoter of the barley B1 hordein gene or by the maize ubiquitin promoter. The transgenes are stably integrated into the barley genome and inherited in the subsequent generation. All transgenic lines show normal phenotypes and are fertile. LL-37 accumulated in the barley seeds up to 0.55mg per 1kg of grain. The fused epitope tags are cleaved off by the use of enterokinase. Furthermore, in planta produced LL-37 including the fused versions is biologically active.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据